US Bancorp
XENE icon

US Bancorp’s Xenon Pharmaceuticals XENE Stock Holding History

US Bancorp’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8K Buy
272
+97
+55% +$4.47K ﹤0.01% 3200
2025
Q4 		$7.84K Hold
175
– – ﹤0.01% 3403
2025
Q3 		$7.03K Sell
175
-6
-3% -$211 ﹤0.01% 3430
2025
Q2 		$5.67K Sell
181
-94
-34% -$3.07K ﹤0.01% 3603
2025
Q1 		$9.23K Sell
275
-311
-53% -$11.8K ﹤0.01% 3463
2024
Q4 		$23K Sell
586
-20
-3% -$827 ﹤0.01% 3097
2024
Q3 		$23.9K Sell
606
-45
-7% -$1.81K ﹤0.01% 3060
2024
Q2 		$25.4K Sell
651
-913
-58% -$36.5K ﹤0.01% 2965
2024
Q1 		$67.3K Buy
1,564
+631
+68% +$29K ﹤0.01% 2545
2023
Q4 		$43K Buy
933
+674
+260% +$23.8K ﹤0.01% 2750
2023
Q3 		$8.85K Hold
259
– – ﹤0.01% 3220
2023
Q2 		$9.97K Buy
+259
New +$10.3K ﹤0.01% 3263

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return